Apimeds Pharmaceuticals US, Inc. (APUS) vs Gelteq Limited (GELS)
Apimeds Pharmaceuticals US, Inc. and Gelteq Limited are both Drug Manufacturers Specialty & Generic companies. Apimeds Pharmaceuticals US, Inc. is the larger, with a market value of $7.6M against $5.9M — 1.3× the size. Across the 8 metrics below, Gelteq Limited leads on 6 and Apimeds Pharmaceuticals US, Inc. on 2.
Valuation
Profitability
| Metric | APUS | GELS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | — | — | 53.94% |
| Operating margin | 0.00% | — | 0.00% |
| Net margin | 0.00% | — | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (100.13%) | 0.00% | (0.40%) |
| Return on assets | (84.20%) | 0.00% | (3.32%) |
| Return on invested capital | (15.96%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack